Suchergebnisse - "Isgrò, Valentina"

PubPharm (34)

1

A real-world multicentre evaluation of atezolizumab plus platinum-etoposide chemotherapy as first-line treatment in patients with extensive-stage small cell lung cancer in Italy

enthalten in: Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners | 2024

von Musicco, F. | Fulgenzio, C. | Malfa, A. | +13

2

Safety and potential interaction of immunosuppressive drugs for the treatment of inflammatory bowel disease in elderly patients

enthalten in: Minerva gastroenterology | 2024

von Ingrasciotta, Y. | Grova, M. | Crispino, F. | +6

3

The lack of head-to-head randomised trials and the consequences for patients and national health service : The case of non-small cell lung cancer

enthalten in: European journal of clinical pharmacology | 2024

von Lasala, R. | Romagnoli, A. | Santoleri, F. | +10

4

Comparing clinical trial population representativeness to real-world users of 17 biologics approved for immune-mediated inflammatory diseases : An external validity analysis of 66,639 biologic users from the Italian VALORE project

enthalten in: Pharmacological research | 2024

von Ingrasciotta, Y. | Spini, A. | L'Abbate, L. | +21

5

The lack of head-to-head randomised trials and the consequences for patients and national health service: The case of non-small cell lung cancer

enthalten in: European journal of clinical pharmacology | 2024

von Lasala, R. | Romagnoli, A. | Santoleri, F. | +10

6

Time to treatment discontinuation in first-line non-small cell lung carcinoma : an overview

enthalten in: Current medical research and opinion | 2023

von Lasala, R. | Zovi, A. | Isgrò, V. | +3

7

Testing of Coding Algorithms for Inflammatory Bowel Disease Identification, as Indication for Use of Biological Drugs, Using a Claims Database from Southern Italy

enthalten in: Clinical epidemiology | 2023

von Ingrasciotta, Y. | Isgrò, V. | Foti, S. | +8

8

Post-Marketing Surveillance of CAR-T-Cell Therapies : Analysis of the FDA Adverse Event Reporting System (FAERS) Database

enthalten in: Drug safety | 2022

von Fusaroli, M. | Isgrò, V. | Cutroneo, P. | +6

9

Post-Marketing Surveillance of CAR-T-Cell Therapies: Analysis of the FDA Adverse Event Reporting System (FAERS) Database

enthalten in: Drug safety | 2022

von Fusaroli, M. | Isgrò, V. | Cutroneo, P. | +6

10

Post-Marketing Surveillance of CAR-T-Cell Therapies: Analysis of the FDA Adverse Event Reporting System (FAERS) Database

enthalten in: Drug safety | 2022

von Fusaroli, M. | Isgrò, V. | Cutroneo, P. | +6